Add Yahoo as a preferred source to see more of our stories on Google. CXCL12 may help scientists mass-produce artificial red blood cells by triggering key steps in their development. (CREDIT: ...

A new Northwestern Medicine study has revealed how a common inherited mutation disrupts red blood cell development and sparks inflammation that can lead to leukemia, according to findings published in ...

A new study describes a technique that rejuvenates aging blood-forming stem cells and could help reduce the risk of age-related blood disorders.

Researchers at the University of Illinois report they can alter blood cell development through the use of biomaterials designed to mimic characteristics of the bone marrow. The findings, reported in ...

Europe produced 58.8 million tonnes of plastics in 2022. — © AFP JOSH EDELSON Europe produced 58.8 million tonnes of plastics in 2022. — © AFP JOSH EDELSON ...

The production of red blood cells from stem cells has emerged as a transformative approach to address chronic blood shortages and meet the increasing demand for transfusion therapies. By harnessing ...

The team observed the emergence of the three-dimensional embryo-like structures under a microscope in the lab. These started producing blood (seen here in red) after around two weeks of development - ...

A collaborative integration model to enable practical, scalable cell and gene therapy delivery. SINGAPORE, March 5, 2026 ...

The first gene therapies approved to treat sickle cell disease in December 2023 are struggling on the market. But there are glimpses of forward momentum as Vertex and Genetix Bio provide updates.